Lipid-lowering therapy and LDL-C control for primary prevention in persons with diabetes across 90 health systems in the United States
Objective: National guidelines recommend statin therapy for patients with type 2 diabetes. We assessed the extent of moderate- to high-intensity statin therapy utilization in community practice. Methods: We evaluated lipid-lowering therapy (LLT) and low-density lipoprotein cholesterol (LDL-C) levels...
Main Authors: | Emily Decicco, Eric D. Peterson, Anand Gupta, Kristin Khalaf Gillard, Evelyn Sarnes, Ann Marie Navar |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-12-01
|
Series: | American Journal of Preventive Cardiology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666667723001459 |
Similar Items
-
The importance of LDL-C lowering in atherosclerotic cardiovascular disease prevention: Lower for longer is better
by: Omar Mhaimeed, et al.
Published: (2024-06-01) -
The role of statins in clinical medicine -LDL - cholesterol lowering and beyond
by: Swiss Medical Weekly
Published: (2006-01-01) -
Statin Use and Adverse Effects Among Adults >75 Years of Age: Insights From the Patient and Provider Assessment of Lipid Management (PALM) Registry
by: Michael G. Nanna, et al.
Published: (2018-05-01) -
Lipid lowering: PCSK9 inhibitors – new kids on the block target their breakthrough
by: Markus Mohaupt
Published: (2016-07-01) -
Anti-flavivirus Properties of Lipid-Lowering Drugs
by: Carlos Noe Farfan-Morales, et al.
Published: (2021-10-01)